2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 108.394 | 103.880 | 185.134 | 292.624 | 319.656 | 322.129 | 351.555 | 461.316 | 470.915 | 486.654 |
Total Income - EUR | 121.620 | 103.880 | 185.134 | 292.624 | 319.657 | 322.877 | 362.486 | 463.236 | 470.932 | 493.225 |
Total Expenses - EUR | 104.892 | 94.035 | 127.427 | 162.289 | 220.250 | 288.438 | 241.130 | 309.209 | 307.485 | 331.619 |
Gross Profit/Loss - EUR | 16.728 | 9.845 | 57.707 | 130.334 | 99.406 | 34.439 | 121.356 | 154.028 | 163.447 | 161.606 |
Net Profit/Loss - EUR | 14.051 | 8.458 | 48.474 | 126.137 | 96.210 | 31.210 | 118.444 | 149.474 | 158.832 | 156.772 |
Employees | 5 | 6 | 6 | 6 | 7 | 7 | 6 | 5 | 5 | 6 |
Check the financial reports for the company - Oftasan S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 76.637 | 53.477 | 111.509 | 137.048 | 123.416 | 143.884 | 118.625 | 82.693 | 69.872 | 67.003 |
Current Assets | 15.765 | 36.672 | 6.811 | 45.395 | 131.082 | 19.945 | 147.140 | 87.799 | 113.000 | 108.641 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 528 | 529 | 1.250 |
Receivables | 2.168 | 2.180 | 4.518 | 2.945 | 5.372 | 3.009 | 14.901 | 1.919 | 1.283 | 97.614 |
Cash | 13.597 | 34.492 | 2.293 | 42.450 | 125.711 | 16.936 | 132.238 | 85.352 | 111.188 | 9.778 |
Shareholders Funds | 74.626 | 83.708 | 109.060 | 133.091 | 226.858 | 137.774 | 253.606 | 155.881 | 165.259 | 163.180 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 17.776 | 6.441 | 9.261 | 49.352 | 27.640 | 26.055 | 12.159 | 14.611 | 17.612 | 12.465 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year |
8622
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Oftasan S.r.l.